IP Library Patent Application 10599928
Patent Application
App. No. 10/599,928

Liquids Containing Suspended Glass Particles

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/599,928
Abstract

Present proposals to use perfluorocarbons as a medium to suspend glass particles presents the problem of aggregation of the particles within the suspending medium. Overcoming this problem requires careful particle sizing and density matching techniques. An additional disadvantage of the large scale use of perfluorocarbons is their contribution to global warming. The inventor has realised that by replacing perfluorocarbons with the more environmentally friendly fluorinated ethers such as hydrofluoroethers or hydrofluoropolyethers a long lasting suspension of glass particles can be achieved without the need for such rigorous particle sizing or density matching processes.

Claims (15)

1 . A formulation comprising an active ingredient preserved in glassy or amorphous particles, the particles being suspended in a liquid in which at least one component comprises a hydrofluoroether, perfluroether, hydrofluroamine, perfluoroamine, hydrofluorothioether, perfluorothioether hydrofluoropolyether, perfluorpolyether or a general formula

R1-X—R2 or

R1-X-(CF2Y) n (CF2CF2Z) m -R2 or

R1-[(X—CF—R2) n -(X—CF2) m ]OR3

where X, Y and Z are defined as O (oxygen), and ether, NR3 (N=nitrogen), an amine or S (sulphur); and each of R1, R2 and R3 are defined as a non-fluorinated, partially fluorinated or fully fluorinated alkyl, cycloalkyl, aryl or arylalkyl group or an organic functional group, halogen group or cyano group.

2 . A formulation according to claim 1 in which the particles contain a sugar glass or a glass which is a mixture of sugar, metal carboxylate, amino acid or calcium phosphate or any combination of these.

3 . A formulation according to claim 1 in which the particles have a density which is matched to the density of the liquid sufficiently closely that the particles will remain in suspension under normal conditions.

4 . A formulation according to claim 1 in which the liquid contains different components specified in claim 1 mixed in proportions to give a required density.

5 . A formulation according to claim 1 in which the liquid contains a perfluorocarbon mixed with one or more components specified in claim 1 .

6 . A formulation according to claim 1 in which the active ingredient is a vaccine.

7 . A formulation according to claim 1 in which the particles are made by spray drying.

8 . A formulation according to claim 1 in which the particles are made by freeze drying.

9 . A formulation according to claim 1 in which the particles are made by grinding.

10 . A method of making a formulation according to claim 4 including the step of selecting liquids to give the required density matching properties and mixing them with the particles.

11 . A formulation comprising an active ingredient preserved in glassy or amorphous particles, the particles being suspended in a liquid comprising a hydrofluoroether.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2010
From: CAMBRIDGE BIOSTABILITY LIMITED
To: NOVA BIO-PHARMA TECHNOLOGIES LIMITED
Reel/Frame 024394/0956 →
DEBENTURE (MORTGAGE/SECURITY INTEREST) Recorded Jul 6, 2009
From: CAMBRIDGE BIOSTABILITY LIMITED
To: NOVA LABORATORIES LIMITED
Reel/Frame 022915/0982 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2006
From: ROSER, BRUCE JOSEPH
To: CAMBRIDGE BIOSTABILITY LIMITED
Reel/Frame 018388/0623 →